M. Shi et al. / Tetrahedron 65 (2009) 3404–3408
3407
3.2. General procedure for the preparation of products 2
6.99–7.01 (m, 2H), 7.16–7.18 (m,1H), 7.23–7.32 (m, 4H, ArH), 9.62 (d,
J¼7.8 Hz, 1H); 13C NMR (CDCl3, 75 MHz, TMS):
d 21.2, 124.7, 125.9,
Compound 1 (0.30 mmol), Pd(OAc)2 (0.030 mmol), and PPh3
(0.18 mmol) were weighed into an oven-dried Schlenk tube, which
was charged with 1.0 mL of toluene. The reaction mixture was then
stirred under ambient atmosphere. Then, 0.30 mmol of triethylamine
(Et3N) was added into the reaction mixture bya syringe. The mixtures
were stirred and heated to 60 ꢀC. After completion of the trans-
formationsmonitoredbyTLCplates,thereactionmixturewasdirectly
transferred to silica gel column and eluted with mixtures of petro-
leum ether and ethyl acetate to afford the corresponding product 2.
128.0, 128.7, 130.4, 131.3, 135.4, 138.4, 152.1, 193.5; MS (EI) m/z (%):
172 (Mþ, 36.98), 157 (12.82), 143 (32.90), 129 (100.00), 128 (83.34),
115 (35.17), 91 (22.70), 65 (28.01), 63 (28.01), 51 (32.88); HRMS (EI)
Calcd for C12H12O 172.0888, found 172.0890.
3.2.6. (2E,4E)-5-(3,4,5-Trimethoxyphenyl)penta-2,4-dienal
Product 2g: R1¼3,4,5-(CH3O)3C6H2;
a yellow solid; mp
n 2999, 2939, 2925, 2828, 2745, 2722, 1946,
119–121 ꢀC; IR (film):
1671,1615,1578,1504,1467,1420,1392,1339,1246,1207,1149,1123,
1006, 988, 882, 843, 734, 574 cmꢁ1 1H NMR (CDCl3, 300 MHz,
TMS):
3.89 (s, 3H, CH3O), 3.92 (s, 6H, CH3O), 6.28 (dd, J¼15.0,
;
3.2.1. (2E,4E)-5-Phenylpenta-2,4-dienal
d
Product 2a: R1¼C6H5; a yellow liquid; IR (film):
n
3339, 3028,
8.1 Hz, 1H), 6.74 (s, 2H, ArH), 6.87–6.99 (m, 2H), 7.18–7.31 (m, 1H),
2822, 2741, 1954, 1674, 1619, 1591, 1492, 1449, 1417, 1389, 1266,
9.63 (d, J¼8.1 Hz, 1H); 13C NMR (CDCl3, 75 MHz, TMS):
d 55.9, 60.7,
1200, 1153, 1117, 1012, 986, 880, 845, 737, 560 cmꢁ1
(CDCl3, 300 MHz, TMS):
6.28 (dd, J¼15.0, 8.1 Hz,1H), 7.01–7.03 (m,
2H), 7.24–7.42 (m, 1H), 7.35–7.53 (m, 5H, ArH), 9.63 (d, J¼8.1 Hz,
;
1H NMR
104.4, 125.4, 130.98, 131.02, 139.4, 142.2, 151.9, 153.2, 193.4; MS (EI)
m/z (%): 248 (Mþ, 100.00), 233 (41.19), 219 (55.60), 188 (52.87), 145
(26.44), 115 (21.97), 91 (18.57), 65 (15.28). Anal. Calcd for C14H16O4:
C, 67.73; H, 6.50. Found: C, 67.54; H, 6.47.
d
1H); 13C NMR (CDCl3, 75 MHz, TMS):
d 126.0, 127.4, 128.8, 129.6,
131.4,135.4, 142.3, 152.0,193.5; MS (EI) m/z (%): 158 (Mþ, 51.64), 130
(36.67), 129 (00.00), 128 (63.03), 115 (29.76), 77 (25.31), 51 (30.63);
HRMS (EI) Calcd for C11H10O 158.0732, found 158.0739.
3.2.7. (2E,4E)-5-(2,5-Dimethoxyphenyl)penta-2,4-dienal
Product 2h: R1¼2,5-(CH3O)2FC6H3; a yellow solid; mp 73–75 ꢀC;
IR (film):
n 3001, 2944, 2835, 1676, 1612, 1493, 1466, 1428, 1293,
3.2.2. (2E,4E)-5-(4-Chlorophenyl)penta-2,4-dienal
1227, 1180, 1156, 1123, 1046, 1021, 988, 804, 717 cmꢁ1
;
1H NMR
Product 2b: R1¼4-ClC6H4; a yellow solid; mp 140–142 ꢀC; IR
(CDCl3, 300 MHz, TMS): 3.80 (s, 3H, CH3O), 3.84 (s, 3H, CH3O), 6.23
d
(film):
n
3032, 2926, 2829, 2744, 1897, 1675, 1622, 1588, 1490, 1408,
(dd, J¼15.0, 7.8 Hz, 1H), 6.82–6.90 (m, 2H), 6.96–7.07 (m, 2H), 7.25
1299, 1275, 1200, 1154, 1114, 1088, 1012, 989, 885, 836, 692,
(d, J¼15.0 Hz, 1H), 7.35 (d, J¼15.6 Hz, 1H), 9.58 (d, J¼7.5 Hz, 1H); 13C
583 cmꢁ1 1H NMR (CDCl3, 300 MHz, TMS):
;
d
6.28 (dd, J¼15.0,
NMR (CDCl3, 75 MHz, TMS): d 55.6, 56.0, 112.1, 112.2, 116.3, 125.0,
7.8 Hz, 1H), 6.97–6.99 (m, 2H), 7.21–7.30 (m, 1H), 7.34–7.37 (m, 2H,
126.7, 131.0, 137.4, 152.1, 153.1, 153.4, 193.7; MS (EI) m/z (%): 218
(Mþ, 100.00), 189 (34.71), 159 (47.82), 144 (49.41), 115 (69.02), 91
(33.51), 77 (45.12), 55 (40.00); HRMS (EI) Calcd for C13H14O3
218.0943, found 218.0935.
ArH), 7.43–7.45 (m, 2H, ArH), 9.63 (d, J¼7.8 Hz, 1H); 13C NMR
(CDCl3, 75 MHz, TMS): d 16.6, 128.5, 129.0, 131.8, 134.0, 135.2, 140.6,
151.4, 193.3; MS (EI) m/z (%): 192 (Mþ, 41.40), 157 (30.03), 129
(100.00), 128 (65.36), 127 (46.14), 75 (18.56), 51 (22.82); HRMS (EI)
Calcd for C11H9ClO 192.0342, found 192.0348.
3.2.8. (2E,4E)-5-(4-Methoxyphenyl)penta-2,4-dienal
Product 2i: R1¼4-CH3OC6H4; a yellow solid; mp 80–82 ꢀC; IR
3.2.3. (2E,4E)-5-(4-Fluorophenyl)penta-2,4-dienal
(film): n 3053, 3034, 2979, 2845, 2753, 1895, 1670, 1622, 1511, 1462,
Product 2d: R1¼4-FC6H4; a yellow solid; mp 81–83 ꢀC; IR
1423, 1402, 1256, 1197, 1177, 1154, 1113, 1017, 990, 839, 808, 737,
(film):
n
3382, 3037, 2848, 2767, 1943, 1897, 1678, 1621, 1591,
560 cmꢁ1; 1H NMR (CDCl3, 300 MHz, TMS):
d
3.85 (s, 3H, CH3O), 6.24
1509, 1467, 1418, 1399, 1266, 1233, 1197, 1155, 1122, 1015, 989,
(dd, J¼15.0, 8.1 Hz, 1H), 6.84–7.01 (m, 3H), 7.22–7.31 (m, 2H, ArH),
896, 841, 738, 552 cmꢁ1 1H NMR (CDCl3, 300 MHz, TMS):
;
d
6.27
7.44–7.48 (m, 2H, ArH), 9.60 (d, J¼8.1 Hz, 1H); 13C NMR (CDCl3,
(dd, J¼15.3, 7.8 Hz, 1H), 6.87–7.97 (m, 2H), 7.02–7.11 (m, 2H,
75 MHz, TMS): d 55.2, 114.2, 123.9, 128.2, 129.0, 130.3, 142.2, 152.7,
ArH), 7.22–7.30 (m, 1H), 7.47–7.52 (m, 2H, ArH), 9.62 (d,
160.8, 193.5; MS (EI) m/z (%): 188 (Mþ, 100.00), 159 (41.60), 144
(44.96),129 (29.94),117 (25.12),115 (51.39), 91 (24.80), 63 (22.37), 51
(18.46); HRMS (EI) Calcd for C12H12O2 188.0837, found 188.0834.
J¼7.8 Hz, 1H); 13C NMR (CDCl3, 75 MHz, TMS):
d 115.9, 116.1,
125.9 (d, J¼2.2 Hz), 129.2 (d, J¼8.7 Hz), 131.6 (d, J¼16.0 Hz),
140.9 (d, J¼2.2 Hz), 151.8, 163.4 (d, J¼249.6 Hz), 193.5; MS (EI)
m/z (%): 176 (Mþ, 100.00), 175 (31.52), 148 (53.95), 147 (93.48),
146 (61.57), 133 (44.99), 127 (38.34), 75 (27.62), 51 (26.34);
HRMS (EI) Calcd for C11H9FO 176.0637, found 176.0627.
3.2.9. (2E,4E)-5-p-Tolylpenta-2,4-dienal
Product 2j: R1¼4-CH3C6H4; a yellow solid; mp 96–98 ꢀC; IR
(film):
n 3050, 3006, 2981, 2847, 2767, 1915, 1667, 1618, 1512,
1453, 1420, 1398, 1266, 1198, 1184, 1155, 1122, 1018, 994, 836,
3.2.4. (2E,4E)-5-(3-(Benzyloxy)phenyl)penta-2,4-dienal
810, 738, 552 cmꢁ1 1H NMR (CDCl3, 300 MHz, TMS):
;
d
2.38 (s,
Product 2e: R1¼3-BnOC6H4; a yellow liquid; IR (film):
n
3064,
3H, CH3), 6.25 (dd, J¼15.3, 8.1 Hz, 1H), 6.91–7.04 (m, 2H), 7.19
(d, J¼7.8 Hz, 2H, ArH), 7.23–7.31 (m, 1H), 7.41 (d, J¼7.8 Hz, 2H,
ArH), 9.61 (d, J¼8.1 Hz, 1H); 13C NMR (CDCl3, 75 MHz, TMS):
3032, 2928, 2872, 1682, 1618, 1582, 1488, 1448, 1382, 1291, 1265,
1160, 1026, 989, 780, 738, 697 cmꢁ1 1H NMR (CDCl3, 300 MHz,
;
TMS):
d
5.80 (s, 2H, PhCH2O), 6.26 (dd, J¼15.3, 8.1 Hz, 1H), 6.96 (d,
d 21.3, 125.1, 127.4, 129.5, 130.9, 132.7, 139.9, 142.5, 152.4, 193.5;
J¼5.4 Hz, 2H), 7.10–7.45 (m, 10H), 9.60 (d, J¼8.1 Hz, 1H); 13C NMR
MS (EI) m/z (%): 172 (Mþ, 55.44), 157 (17.10), 143 (30.89), 129
(CDCl3, 75 MHz, TMS):
d
70.0, 113.5, 116.1, 120.5, 126.4, 127.4, 128.1,
(100.00), 128 (83.60), 127 (25.60), 115 (33.57), 91 (14.09), 77
128.6, 129.9, 131.6, 136.6, 136.9, 142.2, 152.0, 159.1, 193.6; MS (EI)
m/z (%): 264 (Mþ, 2.05), 149 (6.35), 92 (8.98), 91 (100.00), 65
(18.18), 57 (6.52), 51 (4.82), 43 (5.20), 41 (5.16); HRMS (EI) Calcd
for C18H16O2 264.1150, found 264.1140.
(13.58), 65 (13.82), 51 (14.69); HRMS (EI) Calcd for C11H12
172.0888, found 172.0887.
O
3.2.10. Synthesis of d1-1a
3.2.5. (2E,4E)-5-m-Tolylpenta-2,4-dienal
Product 2f: R1¼3-CH3C6H4; a yellow liquid; IR (film):
n 3026,
OH
OD
NaH
THF
D2O
2922, 2855, 2737, 1856, 1674, 1619, 1485, 1455, 1416, 1380, 1266,
Extraction
1154, 1119, 1011, 986, 874, 779, 737, 570 cmꢁ1
300 MHz, TMS):
2.38 (s, 3H, CH3), 6.26 (dd, J¼15.6, 7.8 Hz, 1H),
;
1H NMR (CDCl3,
Ph
Ph
1a
d1-1a
d